PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Completed

Conditions studied: Parkinson Disease

In brief

The PROGENI Family Study is part of a larger consortium that is studying a gene shown to be important in Parkinson's disease, called LRRK2. People who have a defect in the LRRK2 gene will often develop Parkinson's disease. Eligible participants will be asked to complete a single Study Visit at an affiliated research facility closest to their home.

Key facts

Study ID

NCT01536821

Run by

Indiana University

People needed

81

Starts

2011-05-01

Expected to finish

2013-12-01

Last updated by the study team

2013-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Positive for a LRRK2 mutation

Where it is running

• Cleveland Clinic Florida — Weston, Florida, United States
• Indiana University Medical Center — Indianapolis, Indiana, United States
• University of Iowa Hospitals — Iowa City, Iowa, United States
• Kansas University Medical Center — Kansas City, Kansas, United States
• University of Maryland School of Medicine — Baltimore, Maryland, United States
• University of Nebraska — Omaha, Nebraska, United States
• Beth Israel Medical Center — New York, New York, United States
• Medical University of Ohio — Toledo, Ohio, United States
• Oregon Health & Science University — Portland, Oregon, United States
• University of Alberta — Edmonton, Alberta, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.